Graphene: could be ready for our therapies by 2030
Graphene and his siblings are gaining attention for their role in drug delivery systems, photothermal, and photodynamic cancer therapy, and as platforms for combined therapies.
In vivo it's working already, with some potential for a fast development to clinical trials.
Graphene and his siblings are gaining attention for their role in drug delivery systems, photothermal, and photodynamic cancer therapy, and as platforms for combined therapies.
In vivo it's working already, with some potential for a fast development to clinical trials.